Andrew Charlton Consultant Haematologist Newcastle

Andrew Charlton Consultant Haematologist Newcastle

Andrew Charlton Consultant Haematologist Newcastle delivers expert care to patients with blood disorders. He works at the Northern Centre for Cancer Care and focuses on myeloma treatment, apheresis medicine, and transfusion. He also works closely with NHS Blood and Transplant to improve patient outcomes.

Clinical Expertise in Haematology

Dr Andrew Charlton provides advanced treatments for complex blood conditions. He manages myeloma cases and leads apheresis procedures with precision. In addition, he develops effective transfusion practices that support patient recovery. His hands-on approach ensures safe and efficient care for every patient.

Experience and Career Development

After training as a Registrar in the Northern Deanery, Dr Charlton enhanced his expertise through a Clinical Fellowship at the Northern Centre for Cancer Care. There, he joined the Haemato-Oncology Clinical Trials Team and gained significant research experience. He consistently applies this knowledge to improve patient care.

Focus on Clinical Trials and Research

Andrew Charlton Consultant Haematologist Newcastle actively expands the clinical trials portfolio at his Trust. He secured NIHR ‘Greenshoots’ funding to develop research opportunities for patients. Through these trials, patients access cutting-edge therapies while contributing to medical advancement.

Leadership and Professional Roles

Dr Charlton serves as the Clinical Lead for Transfusion and is a member of the Sub-Regional Immunoglobulin Assessment Panel. He also examines candidates for the FRCPath examination, guiding the next generation of haematologists. His leadership drives excellence within the medical community.

Commitment to Patient Care and Innovation

With each role he undertakes, Dr Charlton remains committed to improving treatment options. He combines research, clinical expertise, and leadership to deliver exceptional haematology care. Patients benefit from his dedication to both innovation and compassionate service.